Drug Pipeline

Zongertinib Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
7
Active Studies
3
Recruiting
2
Phase 3
2
Top Sponsors
What Changed in the Last 30 Days
First PostedNew Trial FilingPhaseStatus
2026-06-01 NCT07619066 A Phase II Study of Zongertinib Plus Fulvestrant in Participants With… Phase 2 Not Yet Recruiting
Active Studies by Phase
Phase 3
2
Phase 2
3
Phase 1/2
1
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT07195695 Beamion LUNG-3: Adjuvant Zongertinib vs Standard Treatment in People With Completely… Non-small Cell Lung Cancer Recruiting
NCT06151574 Beamion LUNG-2: A Study to Test Whether Zongertinib (BI 1810631) Helps People With… Lung Cancer, Non-squamous, Non-small Cell Active, Not Recruiting
Phase 2
NCT06581432 Beamion PANTUMOR-1: A Study to Test Whether Zongertinib Helps People With Advanced… Solid Tumours Recruiting
NCT07486817 Beamion 44: A Study to Test How Well Zongertinib is Tolerated by People With Advanced… Lung Cancer, Non-squamous, Non-small Cell Not Yet Recruiting
NCT07619066 A Phase II Study of Zongertinib Plus Fulvestrant in Participants With… Advanced Breast Cancer Not Yet Recruiting
Phase 1/2
NCT06324357 Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in… Metastatic Breast Cancer Recruiting
Phase 1
NCT04886804 Beamion LUNG-1: A Study to Test Different Doses of Zongertinib in People With Different… Neoplasm Metastasis Active, Not Recruiting
Sponsors Running Zongertinib Trials
Disease Areas
Get alerts when Zongertinib trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free